Table II.
Mean (SD)
|
|
---|---|
Demographics
| |
Gender | 19 male, 11 female |
Age (years) | 64.0 (7.7) |
Disease duration (years) | 14.3 (5.6) |
Time since DBS surgery (months) | 22.4 (20.8) |
UPDRS-III score (off medication, off DBS) | 35.5 (10.5) |
Clinically optimized stimulator settings
| |
Voltage (V) | 2.8 (0.7) |
Pulse width (μs) | 62.1 (7.7) |
Frequency (Hz) | 185 (0.0) |
Study stimulation characteristics
| |
Side of stimulation | 14 left, 16 right |
Subjects with clinical contact as study contact | 9 dorsal, 8 ventral |
Voltage (V) | 2.4 (0.2) |
Pulse Width (μs) | 60 (0.0) |
Frequency (Hz) | 185 (0.0) |
Dorsal x (absolute value) | 12.7 (1.0) |
Dorsal y | −17.6 (1.5) |
Dorsal z | −1.6 (0.7) |
Ventral x (absolute value) | 11.8 (1.0) |
Ventral y | −19.5 (1.3) |
Ventral z | −5.3 (0.8) |
Note. Clinically optimized settings are reported for the clinical contact on same side of brain as study stimulation. Average x, y and z position of the study contacts are reported in Mai atlas coordinates.